FDA Orange Book · active-ingredient family
Quazepam
Quazepam is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DORAL · NDA 018708
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DORALRLD×2 | GALT PHARMS | NDA 018708 | — | Dec 27, 1985 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7608616 | Jun 03, 2028 | in 2 yr | U-1012 |
Quazepam — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
